Before submission, ensure all fields are meticulously filled out. Any discrepancy between your corporate registration (CR) data and the form will result in an immediate rejection. Input the correct commercial registration number.
Double-check that all listed timelines match current Hijri and Gregorian calendar requirements utilized by Saudi portals.
Under Saudi domestic tax law, resident entities making payments to non-resident service providers must withhold a percentage of that payment (ranging from 5% to 20%) as Withholding Tax (WHT). However, Saudi Arabia has signed over 55 bilateral Double Taxation Avoidance Agreements (DTAAs) to encourage international trade.
A: No. Form Q7B is used for any Double Taxation Avoidance Agreement (DTAA) between Saudi Arabia and another country. While many examples focus on the UAE due to high cross-border commerce, the form applies to all relevant treaty partners.
A: While both involve verification, they serve completely different purposes. is a tax document filed with ZATCA to claim treaty-based WHT relief on cross-border payments. QVP (Qualification Verification Program) is a mandatory credential verification process for foreign nationals applying for Saudi work visas, managed by the Ministry of Human Resources and Social Development (MHRSD).
Log in to the ZATCA E-Services Portal to upload the completed Q7B, the TRC, and an undertaking from the Saudi entity (Form Q7C). Why It Matters
The Saudi resident payer must complete Form Q7B, outlining the nature of the payment and the specific treaty articles being utilized. 3. Submission to ZATCA
: Once this "verified" Form Q7B is submitted to ZATCA in Saudi Arabia, the tech firm can finally unlock the benefits of the Double Tax Avoidance Agreement (DTAA)
The Definitive Guide to Form Q7B in Saudi Arabia: Achieving Verified Status for Tax Treaty Relief
: For the form to be "verified" or accepted, it typically must be accompanied by a Tax Residency Certificate (TRC)
Form Q7B is an official document issued by the Saudi Food and Drug Authority (SFDA). It is specifically related to the and pharmaceutical products in the Kingdom. The form is part of the SFDA’s Medical Devices Market Regulation (MDMA).
Eases the movement of capital and services between the UAE and KSA.
| Common Cross-Border Scenarios | Parties Involved | |---|---| | UAE-based IT company receiving royalties from a Saudi client | Saudi payer + UAE non-resident | | Bahraini bank receiving interest payments from a Saudi borrower | Saudi payer + Bahraini non-resident | | Kuwaiti consultancy receiving technical fees from a Saudi entity | Saudi payer + Kuwaiti non-resident | | Qatari investor receiving dividend income from Saudi investments | Saudi payer + Qatari non-resident |